Linguamatics opens new regional headquarters in North America

NewsGuard 100/100 Score

Linguamatics, a leader in enterprise text mining, today announced expansion of its US-based operations and opening of a new North American regional headquarters. The company saw significant corporate growth in 2009, with the addition of new pharmaceutical customers combined with expansion in deployment of the I2E semantic knowledge-discovery platform within existing customers. Linguamatics has stepped up recruitment in software development and business operations to meet this increased demand for its agile text mining software. One key new appointment is that of David Keilman as Director, Channels and Alliances, with responsibility for strategic partner relationships.

“2009 proved to be a landmark year for Linguamatics with I2E established as the text mining software of choice within life science and related organizations”

David Keilman brings more than 15 years experience of enterprise sales and partner leadership, having held senior roles at 170 Systems, Sophos and Genuity. David has a strong technology background covering managed hosting services, security software and services, managed network services, storage solutions and ERP workflow integration.

“2009 proved to be a landmark year for Linguamatics with I2E established as the text mining software of choice within life science and related organizations,” commented John M. Brimacombe, Executive Chairman of Linguamatics. “We particularly value the addition of David’s partnering skills to accelerate our growth as we also expand through new business channels.”

“Linguamatics’ strength for answering high-value questions from text is proven,” added David Keilman. “We're seeing exciting partnering opportunities that will provide customers with significant additional value for knowledge discovery and management.”

Linguamatics’ new North American regional headquarters are at the Riverside Center, 275 Grove Street, Suite 2-400, Newton, MA 02466.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Georgetown study raises concerns over aspirin's role in breast cancer treatment